Oncopeptides

Major Shareholding Notification • Nov 9, 2021

Issuer Oncopeptides AB

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument
Instrument	Aktier
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Share loan
Date	08/11/2021
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	4,017,256
Directly held voting rights	0
Indirectly held voting rights	4,017,256
Percentage
Directly held shares	5.33558 %
Directly held voting rights	0 %
Indirectly held voting rights	5.33558 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	5.33558 %	4,017,256
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled	0.05382 %	40,518
Total	5.3894 %	4,057,774

Group total holdings

Voting rights 4,057,774 Percentage of voting rights 5.3894

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Angivet gränsvärde har överskridits på grund av retur av utlånade aktier.

Published

09/11/2021 13:52

Contact

Name Magnus Westerman

Email magnus.westerman@avanza.se

*Source of information has chosen not to submit the data

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25